Who Are The Most Influential People In Vaccines?
com/vaccinenationWho are the mostinfluential people invaccines?
Who are the most influential people inthe global vaccines world?This is the question we asked our blog subscribers, LinkedIn group members andanyone in our contact network to compile a comprehensive list of the Top 50 asnamed by you.The following 50 personalities were picked based on their career achievementswhether this was groundbreaking discovery and research or innovation, funding,lifetime dedication or simply because they might have inspired others to do well.It is great to see that we have representatives from all aspects including industry,governments, philanthropy, academia and even showbiz.Thank you to everyone who has helped us compile the list and please feel free toshare it with your colleagues.blogs.terrapinn.com/vaccinenationTOP 50 vaccine influencers
50No. 50Ewan McGregor,Actor and UNICEF AmbassadorEwan McGregor is on a mission to the ends ofthe earth to immunise some of the hardest-toreach children in the world, following twovaccine trails, or 'cold chains', supported byUnicef.49No. 49Rajeev Venkayya,Executive Vice President, VaccineBusiness Division,TakedaDr. Venkayya is the Executive Vice President,Vaccine Business at Takeda PharmaceuticalsInternational, overseeing Takeda’s globalvaccine enterprise Prior to this he was theDirector of Vaccine Delivery at the Bill &Melinda Gates Foundation, where he wasresponsible for the foundation’s top twopriorities of polio eradication and newvaccine introduction, and investments ofapproximately 500 million/year. Dr.Venkayya was previously the SpecialAssistant to the President and Senior Directorfor Biodefense at the White House.48No. 48Filip Dubovsky,Vice-President Clinical DevelopmentVaccines and Infectious Disease,MedImmuneDr. Filip Dubovsky joined MedImmune inAugust 2006 as director, clinicaldevelopment and was named vicepresident, clinical development, andglobal clinical therapeutic head, vaccinesin July 2008. In this capacity, he leads thevaccine clinical development programsand the vaccine clinical activities forMedImmune's influenza franchise. Priorto joining MedImmune, Dr. Dubovsky heldseveral roles of increasing responsibility insupport of the Malaria Vaccine rapinn.com/vaccinenationTOP 50 vaccine influencers
47No. 5046No. 49Jon Kim Andrus,Chief, Immunization UnitPan American Health OrganizationPierre Morgon,Vice President, Franchise & GlobalMarketing StrategySanofi PasteurDr. Jon Kim Andrus, a public health expert with25 years of experience of working in the field ofvaccines, immunization, and primary care indeveloping countries, has been named deputydirector of the Pan American HealthOrganization, Regional Office for the Americasof the World Health Organization (PAHO/WHO).Dr. Andrus has been serving as lead seniortechnical advisor for PAHO’s immunizationprogram, where he has been a forceful advocatefor spreading the benefits of vaccination.Pierre Morgon has over 25 years experiencein the pharmaceutical industry, in marketingand operations positions as ProductManager, International Group ProductManager, International Marketing Director,Vice President Marketing, VP Business Unit,General Manager and VP Global MarketingOperations.Through these local and global positions, hehas acquired direct experience withblockbuster products in diverse markets(primary care, specialty care, hospital,vaccines, and biotechnology) and manygeographies.45No. 48Thomas Breuer,Senior Vice President, Head ofGlobal Vaccine DevelopmentGSK BiologicalsAccountable for Department of 1200people, covering Clinical R&D (phase I-IV),Epidemiology & Health Economics, Safety(Qualified Person Pharmacovigilance),Medical Governance activities (includingMedical Compiance) as lead physician(CMO) for Biologicals and regionalMedical Affairs n.com/vaccinenationTOP 50 vaccine influencers
44No. 50Dr Jean-Marie Okwo-Bele,Director of Immunization, Vaccinesand Biologicals,WHODr Jean-Marie Okwo-Bele is responsible forstrategic direction, coordination andmanagement of normative and programmaticimmunization activities.During his 27 years in public health, Dr OkwoBele worked at country, regional and globallevels in support of the expansion of childhoodimmunization programmes, contributing topolicy formulation, capacity building,programme planning and evaluation, anddisease surveillance.43No. 49Jerald Sadoff,Chief Medical Officer,CrucellBefore joining Crucell Dr. Sadoff was thePresident and Chief Executive Officer ofAeras Global TB Vaccine Foundation. While atAeras, Dr. Sadoff developed the world'sleading portfolio of TB vaccine candidates,with two of the four candidates currentlybeing tested in Africa in Phase IIB efficacytrials, built a strong network of developmentpartnerships, and created a world-classvaccine manufacturing infrastructure.Prior to jAeras Dr. Sadoff was the ExecutiveDirector of Clinical Development of Vaccinesat Merck.42No. 48Peter Hotez,President,Sabin Vaccine InstituteDr. Peter Hotez leads the Sabin VaccineInstitute and Texas Children’s HospitalCenter for Vaccine Development based atthe Baylor College of Medicine inHouston. His academic research focuseson vaccine development for a wide rangeof neglected tropical diseases around theglobe, as well as studies to increaseawareness about the neglected tropicaldiseases in developing countries and inthe United m/vaccinenationTOP 50 vaccine influencers
4140No. 50No. 49Pedro Alonso,Director,Institute for Global Health ofBarcelona (ISGlobal)Dr. Pedro Alonso started his career inInternational Health 25 years ago as aphysician working in West Africa. Since thenhis work has focused in the key determinantsof morbidity and mortality in the two mostvulnerable population groups in Africa:young children and pregnant women.Some of his most relevant work has beencarried out in malaria, leading to thedevelopment and testing of new controltools for the prevention or treatment of P.falciparum. He has published more than 200papers in international peer reviewedjournals.Stephen Cochi,Senior Advisor to the Director,CDC Center for Global Health (CGH)Stephen L. Cochi, MD, MPH, is Senior Advisorto the Director, CDC Center for Global Health(CGH), on Immunization and the GlobalHealth Initiative, in addition to continuing hisrole as Senior Advisor to the Director, GlobalImmunization Division, National Center forImmunization and Respiratory Diseases.39Julie Gerberding,President,Merck VaccinesDr. Julie Gerberding leads the company's 5 billion global vaccine business. She isresponsible for the commercialization ofthe current portfolio of vaccines, planningfor the introduction of vaccines from thecompany's robust vaccine pipeline, andaccelerating Merck's on-going efforts tobroaden access to its vaccines in thedeveloping world. Dr. Gerberding led theCenters for Disease Control andPrevention (CDC) as director from 2002 to2009. During her tenure at CDC, Dr.Gerberding led the agency during morethan 40 emergency response nn.com/vaccinenationTOP 50 vaccine influencers
3837No. 50No. 49Paulo Ernani Gadelha Vieira,President,Oswaldo Cruz Foundation (Fiocruz)Bill Gates is co-chair of the Bill & MelindaGates Foundation. Along with co-chairMelinda Gates, he shapes and approvesgrantmaking strategies, advocates for thefoundation’s issues, and helps set the overalldirection of the organization.Bill and Melinda Gates work together toexpand opportunity to the world’s mostdisadvantaged people by collaborating withgrantees and partners.Anthony Ford Hutchinson,(ex) Executive Vice President,MerckHe has spent 30 years at Merck, starting in1981 when he joined Merck Frosst Canada inMontreal, where he spent 17 years movingfrom Director of Pharmacology to Senior VicePresident and Site Head.In 1998, Tony moved to Pennsylvania tohead the basic research effort in the USA andworldwide, covering all therapeutic areas. Asan Executive Vice President he becameresponsible for franchise strategies inmultiple disease areas, including Vaccinesand Infectious Diseases.36Jos Vandelaer,Chief of Immunization,UNICEFDr. Jos Vandelaer leads strategydevelopment and program managementand coordination. Dr. Vandelaer has beenworking in immunization since 1996.Dr. Vandelaer has served as a SeniorHealth Specialist as a Global-level WHOfocal point for the Neonatal TetanusElimination program. He also advised onimmunization issues that included policyand strategy development, and providedscientific advice.Prior to that, Dr. Vandelaer had served inWHO as a Medical Officer in India,Philippines, and om/vaccinenationTOP 50 vaccine influencers
3534No. 50No. 49Christian Loucq,Director General,International Vaccine InstituteDr. Loucq has over 30 years of professionalexperience in medicine, vaccines,pharmaceuticals, and global health globally.In addition, he managed vaccine businessesin China, India and Thailand, and worked withvaccine companies such as GlaxoSmithKlineand Sanofi Pasteur, and biotechnologycompanies such as Rhein Biotech andAcambis. Most recently, Dr. Loucq was theDirector of the Malaria Vaccine Initiative(MVI), a product development partnershipbased at PATH in the U.S.Christopher Elias,President, Global Development,Bill & Melinda Gates FoundationDr. Chris Elias leads the foundation’s effortsin integrated and innovative delivery, findingcreative new ways to ensure solutions andproducts get into the hands of people indeveloping countries who need them most.Dr. Elias most recently served as thepresident and CEO of PATH, dedicated toimproving the health of people around theworld by advancing technologies,strengthening systems, and encouraginghealthy behaviors. Elias currently serves onvarious advisory boards, including the NikeFoundation and the Duke Global HealthInstitute.33Wayne Koff,Senior Vice President and CSO,International Vaccine AIDSInitiativeWayne C. Koff is an internationallyrecognized leader in AIDS vaccineresearch and development. He has beenhonored twice by the United StatesDepartment of Health and HumanServices with the Special Act of ServiceAward for developing innovativestrategies to accelerate the developmentof AIDS vaccines. He oversees IAVI’sprograms in AIDS vaccine research,discovery and development. Prior tojoining IAVI, Wayne served between 1992and 1998 as vice president, VaccineResearch and Development at UnitedBiomedical, Inc., where he wasresponsible for the vaccine R&D om/vaccinenationTOP 50 vaccine influencers
3231No. 50No. 49Manica Balasegaram,Executive Director,MSF Access CampaignMSF’s Access Campaign has been working tohelp MSF medical teams get access toaffordable and effective medicines, suited tothe environments where we operate, for wellover a decade now.Over ten years on and our medical teams stillface the same kind of medical challengesdaily, in treating people with drugs, tests andvaccines that aren’t ideal or suited to theenvironments where they live. MSF’s AccessCampaign continues to work with MSF teamsin the field to identify the problems and workto overcome them.Norman Baylor,President & CEO,Biologics Consulting GroupDr. Norman W. Baylor was formerly theDirector of the Office of Vaccines Researchand Review (OVRR) in the Food and DrugAdministration’s Center for BiologicsEvaluation and Research. Prior to hisposition as Director, Dr. Baylor served asDeputy Director of OVRR and AssociateDirector for Regulatory Policy. He hasevaluated and facilitated the developmentand licensure of numerous new vaccines suchas acellular pertussis, varicella,pneumococcal conjugate, humanpapillomavirus (HPV), influenza, Zoster andall of the new generation combinationvaccines during his 20 year career at FDA.30Barton Haynes,Director of the Human VaccineInstitute ,Duke University School of MedicineBarton Ford Haynes is a U.S. physician andimmunologist and is internationallyrecognized for work in T-cell immunology,retrovirology and HIV vaccinedevelopment. Haynes is a Frederic M.Hanes Professor of Medicine andImmunology at Duke University MedicalCenter. He is the Director of the DukeHuman Vaccine Institute and the Centerfor HIV/AIDS Vaccine Immunology (CHAVI)funded by the NIAID in 2005. He leads theHaynes Vaccine Discovery Consortia aspart of the Collaboration for AIDS VaccineDiscovery (CAVD) funded by the Bill andMelinda Gates Foundation in vaccinenationTOP 50 vaccine influencers
2928No. 50No. 49Peter Paradiso,(ex) Vice President, New Businessand Scientific Affairs,PfizerPeter R. Paradiso, recently retired as VicePresident, New Business and Scientific Affairsfor Pfizer Vaccines, a Division of Pfizer. In thisposition, he was responsible for globalscientific affairs and strategic planning withinthe vaccine research and development groupand for commercial oversight of products indevelopment. He has worked in the field ofvaccine development for the past 28 years.Dr. Paradiso has published broadly in thefield of pediatric vaccines, especially in theareas of glycoconjugates, combinationvaccines and respiratory viral vaccines.Ian Frazer,CEO & Director of Research,Translational Research InstituteIan Hector Frazer is the CEO and Director ofResearch of the Translational ResearchInstitute. In parallel with researchers at theNational Cancer Institute, GeorgetownUniversity, and University of Rochester,Frazer and his colleagues developed andpatented the basic technology behind theHPV vaccine against cervical cancer; thesecond cancer preventing vaccine, and thefirst vaccine designed to prevent a cancer.27George Siber,Executive Chairman,GenoceaDr. Siber, most recently Executive VicePresident and Chief Scientific Officer ofWyeth Vaccines, is a leading authority onvaccines. While at Wyeth, Dr. Siberoversaw the development and approval ofmultiple widely-used childhood vaccines,including Prevnar . Prior to Wyeth, Dr.Siber was Director of the MassachusettsPublic Health Biologic Laboratories and aHarvard Medical School AssociateProfessor of Medicine at Dana FarberCancer .com/vaccinenationTOP 50 vaccine influencers
2625No. 50No. 49Orin Levine,Director of Vaccine Delivery,Bill & Melinda Gates FoundationDr. Orin Levine is Director of Vaccine Deliveryat the Bill and Melinda Gates Foundation,where he leads the Foundation’s efforts toaccelerate the introduction of new vaccinesand related technologies and to improveroutine immunization systems. He is theFoundation’s focal point for engagementwith the GAVI Alliance, whose mission issaving children’s lives by increasing access toimmunization in poor countries.Before that he was Executive Director of IVACand Professor of International Health at theJohns Hopkins Bloomberg School of PublicHealth.Gregory Poland,Director,Mayo ClinicDr. Gregory Poland is the Director of MayoClinic’s Vaccine Research Group – a state-ofthe-art research group and laboratory thatinvestigates issues surrounding vaccineresponse, vaccine policy, and novel vaccinesimportant to public health. Dr. Poland is aProfessor of Medicine and InfectiousDiseases, the Director of the ImmunizationClinic and the Director of the Program inTranslational Immunovirology andBiodefense at the Mayo Clinic. He is theEditor-in-Chief for the journal “Vaccine.”24William Foege,EpidemiologistWilliam H. Foege is an epidemiologist whoworked in the successful campaign toeradicate smallpox in the 1970s. Dr. Foegebecame Chief of the Centers for DiseaseControl and Prevention (CDC) SmallpoxErad
being tested in Africa in Phase IIB efficacy trials, built a strong network of development partnerships, and created a world-class vaccine manufacturing infrastructure. Prior to jAeras Dr. Sadoff was the Executive Director of Clinical Development of Vaccines at Merck. Dr Jean-Marie Okwo-Bele
May 02, 2018 · D. Program Evaluation ͟The organization has provided a description of the framework for how each program will be evaluated. The framework should include all the elements below: ͟The evaluation methods are cost-effective for the organization ͟Quantitative and qualitative data is being collected (at Basics tier, data collection must have begun)
Silat is a combative art of self-defense and survival rooted from Matay archipelago. It was traced at thé early of Langkasuka Kingdom (2nd century CE) till thé reign of Melaka (Malaysia) Sultanate era (13th century). Silat has now evolved to become part of social culture and tradition with thé appearance of a fine physical and spiritual .
On an exceptional basis, Member States may request UNESCO to provide thé candidates with access to thé platform so they can complète thé form by themselves. Thèse requests must be addressed to esd rize unesco. or by 15 A ril 2021 UNESCO will provide thé nomineewith accessto thé platform via their émail address.
̶The leading indicator of employee engagement is based on the quality of the relationship between employee and supervisor Empower your managers! ̶Help them understand the impact on the organization ̶Share important changes, plan options, tasks, and deadlines ̶Provide key messages and talking points ̶Prepare them to answer employee questions
Dr. Sunita Bharatwal** Dr. Pawan Garga*** Abstract Customer satisfaction is derived from thè functionalities and values, a product or Service can provide. The current study aims to segregate thè dimensions of ordine Service quality and gather insights on its impact on web shopping. The trends of purchases have
L’ARÉ est également le point d’entrée en as de demande simultanée onsommation et prodution. Les coordonnées des ARÉ sont présentées dans le tableau ci-dessous : DR Clients Téléphone Adresse mail Île de France Est particuliers 09 69 32 18 33 are-essonne@enedis.fr professionnels 09 69 32 18 34 Île de France Ouest
Chính Văn.- Còn đức Thế tôn thì tuệ giác cực kỳ trong sạch 8: hiện hành bất nhị 9, đạt đến vô tướng 10, đứng vào chỗ đứng của các đức Thế tôn 11, thể hiện tính bình đẳng của các Ngài, đến chỗ không còn chướng ngại 12, giáo pháp không thể khuynh đảo, tâm thức không bị cản trở, cái được
Le genou de Lucy. Odile Jacob. 1999. Coppens Y. Pré-textes. L’homme préhistorique en morceaux. Eds Odile Jacob. 2011. Costentin J., Delaveau P. Café, thé, chocolat, les bons effets sur le cerveau et pour le corps. Editions Odile Jacob. 2010. Crawford M., Marsh D. The driving force : food in human evolution and the future.
